Risk of incident cancer, excluding keratinocyte carcinoma, in patients with psoriasis treated with biologic therapy: a prospective cohort study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group

Shamarke Esse; Oras Alabas; Kayleigh Mason; Sarah Ryan; Nick J. Reynolds; Catherine Smith; Adele Green; Richard B. Warren

doi:10.1093/bjd/ljae090.099

Risk of incident cancer, excluding keratinocyte carcinoma, in patients with psoriasis treated with biologic therapy: a prospective cohort study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group

Shamarke Esse, Oras Alabas, Kayleigh Mason, Sarah Ryan, Nick J. Reynolds, Catherine Smith, Adele Green, Richard B. Warren

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	P072
Pages (from-to)	i48
Number of pages	1
Journal	British Journal of Dermatology
Volume	191
Early online date	28 Jun 2024
DOIs	https://doi.org/10.1093/bjd/ljae090.099
Publication status	Published - 1 Jul 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/bjd/ljae090.099

Cite this

Esse, S., Alabas, O., Mason, K., Ryan, S., Reynolds, N. J., Smith, C., Green, A., & Warren, R. B. (2024). Risk of incident cancer, excluding keratinocyte carcinoma, in patients with psoriasis treated with biologic therapy: a prospective cohort study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group. British Journal of Dermatology, 191, i48. Article P072. https://doi.org/10.1093/bjd/ljae090.099

Esse, Shamarke ; Alabas, Oras ; Mason, Kayleigh et al. / Risk of incident cancer, excluding keratinocyte carcinoma, in patients with psoriasis treated with biologic therapy : a prospective cohort study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group. In: British Journal of Dermatology. 2024 ; Vol. 191. pp. i48.

@article{4383297cd2514b4e96f5a688fd62b3da,

title = "Risk of incident cancer, excluding keratinocyte carcinoma, in patients with psoriasis treated with biologic therapy: a prospective cohort study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group",

author = "Shamarke Esse and Oras Alabas and Kayleigh Mason and Sarah Ryan and Reynolds, {Nick J.} and Catherine Smith and Adele Green and Warren, {Richard B.}",

year = "2024",

month = jul,

day = "1",

doi = "10.1093/bjd/ljae090.099",

language = "English",

volume = "191",

pages = "i48",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "John Wiley & Sons Ltd",

}

Esse, S, Alabas, O, Mason, K, Ryan, S, Reynolds, NJ, Smith, C, Green, A & Warren, RB 2024, 'Risk of incident cancer, excluding keratinocyte carcinoma, in patients with psoriasis treated with biologic therapy: a prospective cohort study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group', British Journal of Dermatology, vol. 191, P072, pp. i48. https://doi.org/10.1093/bjd/ljae090.099

Risk of incident cancer, excluding keratinocyte carcinoma, in patients with psoriasis treated with biologic therapy: a prospective cohort study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group. / Esse, Shamarke; Alabas, Oras; Mason, Kayleigh et al.
In: British Journal of Dermatology, Vol. 191, P072, 01.07.2024, p. i48.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Risk of incident cancer, excluding keratinocyte carcinoma, in patients with psoriasis treated with biologic therapy

T2 - a prospective cohort study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group

AU - Esse, Shamarke

AU - Alabas, Oras

AU - Mason, Kayleigh

AU - Ryan, Sarah

AU - Reynolds, Nick J.

AU - Smith, Catherine

AU - Green, Adele

AU - Warren, Richard B.

PY - 2024/7/1

Y1 - 2024/7/1

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:001261806400043&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1093/bjd/ljae090.099

DO - 10.1093/bjd/ljae090.099

M3 - Meeting Abstract

SN - 0007-0963

VL - 191

SP - i48

JO - British Journal of Dermatology

JF - British Journal of Dermatology

M1 - P072

ER -

Esse S, Alabas O, Mason K, Ryan S, Reynolds NJ, Smith C et al. Risk of incident cancer, excluding keratinocyte carcinoma, in patients with psoriasis treated with biologic therapy: a prospective cohort study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group. British Journal of Dermatology. 2024 Jul 1;191:i48. P072. Epub 2024 Jun 28. doi: 10.1093/bjd/ljae090.099

Risk of incident cancer, excluding keratinocyte carcinoma, in patients with psoriasis treated with biologic therapy: a prospective cohort study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group

UN SDGs

Access to Document

Other files and links

Cite this